Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOLUTEGRAVIR\RILPIVIRINE Cause Hypertension? 29 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Hypertension have been filed in association with DOLUTEGRAVIR\RILPIVIRINE. This represents 2.4% of all adverse event reports for DOLUTEGRAVIR\RILPIVIRINE.

29
Reports of Hypertension with DOLUTEGRAVIR\RILPIVIRINE
2.4%
of all DOLUTEGRAVIR\RILPIVIRINE reports
4
Deaths
10
Hospitalizations

How Dangerous Is Hypertension From DOLUTEGRAVIR\RILPIVIRINE?

Of the 29 reports, 4 (13.8%) resulted in death, 10 (34.5%) required hospitalization, and 5 (17.2%) were considered life-threatening.

Is Hypertension Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOLUTEGRAVIR\RILPIVIRINE. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does DOLUTEGRAVIR\RILPIVIRINE Cause?

Product dose omission issue (281) Fatigue (53) Product use issue (51) Death (47) Rash (46) Viral load increased (45) Diarrhoea (42) Weight increased (40) Headache (38) Nausea (34)

What Other Drugs Cause Hypertension?

ADALIMUMAB (9,032) METHOTREXATE (7,143) RITUXIMAB (6,760) PREDNISONE (6,087) INFLIXIMAB (5,874) ETANERCEPT (5,677) TOCILIZUMAB (5,492) ABATACEPT (5,114) TOFACITINIB (4,991) ALENDRONATE (4,373)

Which DOLUTEGRAVIR\RILPIVIRINE Alternatives Have Lower Hypertension Risk?

DOLUTEGRAVIR\RILPIVIRINE vs DOMPERIDONE DOLUTEGRAVIR\RILPIVIRINE vs DOMPERIDONE\PANTOPRAZOLE DOLUTEGRAVIR\RILPIVIRINE vs DONANEMAB-AZBT DOLUTEGRAVIR\RILPIVIRINE vs DONEPEZIL DOLUTEGRAVIR\RILPIVIRINE vs DONEPEZIL\DONEPEZIL

Related Pages

DOLUTEGRAVIR\RILPIVIRINE Full Profile All Hypertension Reports All Drugs Causing Hypertension DOLUTEGRAVIR\RILPIVIRINE Demographics